Published in Crit Care Med on May 01, 2005
Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care (2008) 1.22
Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms. Heart Fail Rev (2010) 1.18
Molecular events in the cardiomyopathy of sepsis. Mol Med (2008) 1.18
When apoptosis meets autophagy: deciding cell fate after trauma and sepsis. Trends Mol Med (2009) 1.17
Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. J Biol Chem (2011) 1.00
Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice. Circ Heart Fail (2013) 0.99
Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta (2013) 0.93
Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling. Br J Pharmacol (2013) 0.91
The role of the Hsp90/Akt pathway in myocardial calpain-induced caspase-3 activation and apoptosis during sepsis. BMC Cardiovasc Disord (2013) 0.90
Yohimbine promotes cardiac NE release and prevents LPS-induced cardiac dysfunction via blockade of presynaptic α2A-adrenergic receptor. PLoS One (2013) 0.89
Personalizing blood pressure management in septic shock. Ann Intensive Care (2015) 0.86
Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice. Mol Ther Nucleic Acids (2016) 0.84
Management of severe crush injury in a front-line tent ICU after 2008 Wenchuan earthquake in China: an experience with 32 cases. Crit Care (2009) 0.82
Role of Kir6.2 subunits of ATP-sensitive potassium channels in endotoxemia-induced cardiac dysfunction. Cardiovasc Diabetol (2013) 0.82
PPARγ signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPS. Front Pharmacol (2014) 0.81
Rac-induced left ventricular dilation in thyroxin-treated ZmRacD transgenic mice: role of cardiomyocyte apoptosis and myocardial fibrosis. PLoS One (2012) 0.78
Systematic review of use of β-blockers in sepsis. J Anaesthesiol Clin Pharmacol (2015) 0.78
β₁-adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis through activating PKA and enhancing CaMKII and IκBα phosphorylation. Crit Care (2015) 0.77
Oxidative-Nitrosative Stress and Myocardial Dysfunctions in Sepsis: Evidence from the Literature and Postmortem Observations. Mediators Inflamm (2016) 0.76
Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res (2016) 0.76
Methylprednisolone Protects Cardiac Pumping Mechanics from Deteriorating in Lipopolysaccharide-Treated Rats. Front Physiol (2015) 0.75
Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes. Mol Med Rep (2015) 0.75
Is cell death a prerequisite for cardiac dysfunction during sepsis? Crit Care Med (2005) 0.75
Dietary Apigenin Exerts Immune-Regulatory Activity in Vivo by Reducing NF-κB Activity, Halting Leukocyte Infiltration and Restoring Normal Metabolic Function. Int J Mol Sci (2016) 0.75
The Methanol Extract of Azadirachta indica A. Juss Leaf Protects Mice Against Lethal Endotoxemia and Sepsis. Biomol Ther (Seoul) (2012) 0.75
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest (2009) 4.39
The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab (2007) 2.84
American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res (2007) 2.71
Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest (2007) 2.25
ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis. Pediatr Crit Care Med (2006) 2.19
IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2007) 1.91
Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc Res (2009) 1.82
Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg (2007) 1.75
A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. Am J Respir Crit Care Med (2012) 1.74
The Pediatric Multiple Organ Dysfunction Score (P-MODS): development and validation of an objective scale to measure the severity of multiple organ dysfunction in critically ill children. Crit Care Med (2005) 1.73
Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med (2004) 1.63
Tear me down: role of calpain in the development of cardiac ventricular hypertrophy. Circ Res (2011) 1.61
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics (2004) 1.60
Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy. Mol Cell Biol (2011) 1.55
The ubiquitin-proteasome system in cardiac dysfunction. Biochim Biophys Acta (2008) 1.53
Proteasome inhibition promotes regression of left ventricular hypertrophy. Am J Physiol Heart Circ Physiol (2007) 1.50
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2010) 1.48
Sodium/hydrogen exchange activity in sepsis and in sepsis complicated by previous injury: 31P and 23Na NMR study. Crit Care Med (2005) 1.46
Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med (2002) 1.46
Cystic fibrosis: newborn screening in America. MLO Med Lab Obs (2008) 1.42
Nitric oxide donors alter cardiomyocyte cytokine secretion and cardiac function. Crit Care Med (2005) 1.41
Protective role of heat stress in burn trauma. Crit Care Med (2004) 1.41
Persistent low concentration of human chorionic gonadotropin in a nonpregnant woman. Clin Chem (2007) 1.39
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation (2007) 1.34
Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol (1985) (2003) 1.28
IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock (2002) 1.22
Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation (2012) 1.19
Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am J Physiol Heart Circ Physiol (2003) 1.19
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. Cardiovasc Res (2009) 1.18
Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation (2006) 1.17
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res (2009) 1.16
Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury. Am J Physiol Heart Circ Physiol (2004) 1.09
The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun. Am J Pathol (2011) 1.06
Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res (2006) 1.06
NF-κB inhibition protects against tumor-induced cardiac atrophy in vivo. Am J Pathol (2011) 1.05
Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am J Physiol Heart Circ Physiol (2007) 1.05
Back to your heart: ubiquitin proteasome system-regulated signal transduction. J Mol Cell Cardiol (2011) 1.05
Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduct-mediated cytokine/chemokine release by rat sinusoidal liver endothelial and Kupffer cells. Alcohol Clin Exp Res (2004) 1.00
Tearin' up my heart: proteolysis in the cardiac sarcomere. J Biol Chem (2011) 0.99
IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. Am J Physiol Heart Circ Physiol (2003) 0.98
Burn-induced impairment of cardiac contractile function is due to gut-derived factors transported in mesenteric lymph. Shock (2002) 0.97
Cardiac mitochondrial damage and loss of ROS defense after burn injury: the beneficial effects of antioxidant therapy. J Appl Physiol (1985) (2006) 0.97
Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol (2005) 0.97
Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock. Am J Physiol Heart Circ Physiol (2004) 0.96
The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. Am J Physiol Heart Circ Physiol (2011) 0.94
Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clin Exp Pharmacol Physiol (2012) 0.94
Familial hypertrophic cardiomyopathy: basic concepts and future molecular diagnostics. Clin Biochem (2009) 0.94
Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease. Proc Natl Acad Sci U S A (2013) 0.93
Interference of monoclonal antibody therapies with serum protein electrophoresis tests. Clin Chem (2010) 0.92
Cardiac molecular signaling after burn trauma. J Burn Care Res (2006) 0.92
Regulation of AMPK by the ubiquitin proteasome system. Am J Pathol (2010) 0.92
You spin me round: MaFBx/Atrogin-1 feeds forward on FOXO transcription factors (like a record). Cell Cycle (2007) 0.92
Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells. Comp Hepatol (2004) 0.90
Gender-related differences in myocardial inflammatory and contractile responses to major burn trauma. Am J Physiol Heart Circ Physiol (2003) 0.90
Proteotoxicity and cardiac dysfunction. N Engl J Med (2013) 0.89
Cardiac mitochondrial damage and inflammation responses in sepsis. Surg Infect (Larchmt) (2007) 0.89
Increasing percent burn is correlated with increasing inflammation in an adult rodent model. Shock (2008) 0.89
Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion (2007) 0.89
Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 0.88
Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol. Biochem Pharmacol (2005) 0.88
Pediatric critical care medicine: planning for our research future. Pediatr Crit Care Med (2003) 0.88
All the little pieces. -Regulation of mitochondrial fusion and fission by ubiquitin and small ubiquitin-like modifer and their potential relevance in the heart.-. Circ J (2011) 0.88
Merits of non-invasive rat models of left ventricular heart failure. Cardiovasc Toxicol (2011) 0.88
Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res (2010) 0.88
I kappa B overexpression in cardiomyocytes prevents NF-kappa B translocation and provides cardioprotection in trauma. Am J Physiol Heart Circ Physiol (2003) 0.87
Seek and destroy: the ubiquitin----proteasome system in cardiac disease. Curr Hypertens Rep (2009) 0.87
Cardiac effects of burn injury complicated by aspiration pneumonia-induced sepsis. Am J Physiol Heart Circ Physiol (2003) 0.87
Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia. J Cachexia Sarcopenia Muscle (2013) 0.87
CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock (2007) 0.86
Burn trauma alters calcium transporter protein expression in the heart. J Appl Physiol (1985) (2004) 0.86
Cardiomyocyte intracellular calcium and cardiac dysfunction after burn trauma. Crit Care Med (2002) 0.86
Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all. Expert Rev Mol Diagn (2010) 0.85
Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir). PLoS One (2013) 0.84
Murine in vivo myocardial contractile dysfunction after burn injury is exacerbated by pneumonia sepsis. Shock (2005) 0.84
Hypertonic saline dextran after burn injury decreases inflammatory cytokine responses to subsequent pneumonia-related sepsis. Am J Physiol Heart Circ Physiol (2005) 0.84
Association of mitochondrial allele 4216C with increased risk for sepsis-related organ dysfunction and shock after burn injury. Shock (2010) 0.83
Burn plasma mediates cardiac myocyte apoptosis via endotoxin. Am J Physiol Heart Circ Physiol (2002) 0.83
TLR4 inactivation and rBPI(21) block burn-induced myocardial contractile dysfunction. Am J Physiol Heart Circ Physiol (2002) 0.83
Regulation of large conductance Ca2+-activated K+ (BK) channel β1 subunit expression by muscle RING finger protein 1 in diabetic vessels. J Biol Chem (2014) 0.82
Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci (2004) 0.82
Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction. Shock (2008) 0.82
Age-dependent differences of interleukin-6 activity in cardiac function after burn complicated by sepsis. Burns (2009) 0.82
Performance comparison of capillary and agarose gel electrophoresis for the identification and characterization of monoclonal immunoglobulins. Am J Clin Pathol (2008) 0.82
Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans. Hum Genet (2014) 0.82
Usefulness of external counterpulsation early postoperatively after the Fontan procedure in children. Am J Cardiol (2002) 0.82
Endothelial inflammatory transcriptional responses to an altered plasma exposome following inhalation of diesel emissions. Inhal Toxicol (2015) 0.82